leon-nanodrugs GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:leon-nanodrugs GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11013
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leon-Nanodrugs GmbH (Leon-Nanodrugs) is a drug development company that discovers and develops nanotechnology based drug delivery systems. The company develops oral and parenteral products. Its products portfolio includes nanoparticles and drug-delivery-systems such as functionalized multilayer nanoparticles, multilayer nanoparticles, polymer coated API nanoparticles, coated nanoemulsions, nanoemulsions, and others. Leon-Nanodrugs offer its products in oral formulations such as liquids, tablets, capsules, and medical chewing gums, among others. It also provides services related to conception and consulting, patent, regulatory clearance, pre-clinical profiling, regulatory, documentation, and clinical trials, among others. The company serves biotechnology, nanotechnology, and clinical research and pharmaceutical industries. It has its operations in Germany and the US. Leon-Nanodrugs is headquartered in Munich, Germany.

leon-nanodrugs GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
leon-nanodrugs GmbH, Medical Devices Deals, 2012 to YTD 2018 9
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Leon-Nanodrugs Raises USD20.3 Million in Series A Financing 11
Partnerships 12
leon-nanodrugs Enters into Agreement with Takeda Pharma 12
leon-nanodrugs Enters into Agreement with Bionpharma 13
leon-nanodrugs GmbH – Key Competitors 14
leon-nanodrugs GmbH – Key Employees 15
leon-nanodrugs GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jan 09, 2017: leon Appoints Pharma Expert Michael Mehler as Chief Executive Officer 17
Jan 09, 2017: leon-nanodrugs Appoints Pharma Expert Michael Mehler as Chief Executive Officer 18
Product News 19
Jan 16, 2017: leon-nanodrugs partners with Bionpharma for development of a MicroJet Reactor (MJR) based dermatological product 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Key Facts 2
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
leon-nanodrugs GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
leon-nanodrugs GmbH, Medical Devices Deals, 2012 to YTD 2018 9
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Leon-Nanodrugs Raises USD20.3 Million in Series A Financing 11
leon-nanodrugs Enters into Agreement with Takeda Pharma 12
leon-nanodrugs Enters into Agreement with Bionpharma 13
leon-nanodrugs GmbH, Key Competitors 14
leon-nanodrugs GmbH, Key Employees 15
leon-nanodrugs GmbH, Subsidiaries 16

List of Figures
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
leon-nanodrugs GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
leon-nanodrugs GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[leon-nanodrugs GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Union Bank of India:企業のM&A・事業提携・投資動向
    Union Bank of India - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Union Bank of India Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Altri SGPS SA (ALTR):企業の財務・戦略的SWOT分析
    Altri SGPS SA (ALTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Xcel Energy Inc:発電所・企業SWOT分析
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • NovaDigm Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, ALS3 vaccines, vaccine clinical supplies, bacterial and fungal vaccine antigens, vaginal …
  • Pabst Brewing Company:企業の戦略・SWOT・財務分析
    Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report Summary Pabst Brewing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Panhandle Oil and Gas Inc. (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • STMicroelectronics N.V. (STM)-エネルギー分野:企業M&A・提携分析
    Summary STMicroelectronics N.V. (ST) is a microelectronics company that designs, develops, manufactures, and markets a broad range of products for analog, digital, and mixed-signal applications. It offers standard commodity components, custom devices and semi-custom devices, application-specific int …
  • The Kroger Co:企業のM&A・事業提携・投資動向
    The Kroger Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Kroger Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • GOBARTO S.A.:企業の戦略・SWOT・財務情報
    GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report Summary GOBARTO S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • MicroPort Scientific Corp (853)-医療機器分野:企業M&A・提携分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, el …
  • Concho Resources Inc (CXO):石油・ガス:M&Aディール及び事業提携情報
    Summary Concho Resources Inc (Concho) is an oil and gas company that acquires, develops and explores oil and natural gas properties. The company owns and operates exploration assets in the Permian Basin region of Southeast New Mexico and West Texas, an onshore oil and natural gas basin in the US. Co …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AutoGenomics Inc-医療機器分野:企業M&A・提携分析
    Summary AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics' unique proprietary BioFilmChip …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業の財務・戦略的SWOT分析
    China Aviation Oil (Singapore) Corporation Ltd (G92) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline …
  • POSCO ICT Company Ltd. (022100):企業の財務・戦略的SWOT分析
    POSCO ICT Company Ltd. (022100) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Bemis Company Inc (BMS):企業の財務・戦略的SWOT分析
    Bemis Company Inc (BMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Barton Malow Company:企業の戦略・SWOT・財務情報
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Florida Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Florida Power & Light Company (FPL), a subsidiary of NextEra Energy, Inc., is a vertically-integrated electric utility that generates, transmits and distributes electricity. The company generates electricity from oil, natural gas, coal, nuclear and solar sources. It also purchases power and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆